Efficacy and safety of gemcitabine-fluorouracil combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomized controlled trials
about
Biomarkers and Targeted Therapy in Pancreatic CancerGemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia.Gemcitabine plus cisplatin versus gemcitabine alone in the treatment of pancreatic cancer: a meta-analysisPrognostic factors of survival in patients treated with nab-paclitaxel plus gemcitabine regimen for advanced or metastatic pancreatic cancer: a single institutional experienceMeta-analyses of treatment standards for pancreatic cancer.Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death.Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TAp63.Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death.Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanoparticles for the treatment of pancreatic cancer.The combination of curcumin and 5-fluorouracil in cancer therapy.Immunohistochemical expression profiles of solute carrier transporters in alpha-fetoprotein-producing gastric cancer.Towards an optimal treatment algorithm for metastatic pancreatic ductal adenocarcinoma (PDA).Postoperative hepatic arterial infusion chemotherapy improved survival of pancreatic cancer after radical pancreatectomy: a retrospective study.Advanced pancreatic cancer: The standard of care and new opportunities
P2860
Q26752755-A86216FE-CE3C-48C6-AB0E-57551862A0AEQ33421322-231D91F5-48AA-4FEF-9FF3-1643A32938ACQ33430378-FC5384F2-0B6C-4055-A4AE-6E3A10C91CDDQ35781556-52868EA5-7553-45FB-A992-45A85FBB8057Q36640493-7F259B79-31B8-43B4-8F54-96BF9804AC44Q37167523-EDBEEA00-4AD0-4D89-A8C5-631B2AC1C06DQ37687744-A734FCD7-53B8-43C8-9C40-EB6891CF8346Q38827698-8271A777-A9F4-4AB6-AEC7-D8DD229BFB63Q45062589-93B3E608-4207-4891-B8F8-AADD3B2A581FQ47577912-78AAB3F1-6783-4EBD-8048-B5155CAD433BQ51728141-5A67E990-6DE3-41F4-BFD9-1D79B3271CBBQ52673084-250B4A1E-AF79-4FD1-A212-A0BE448E6DA6Q52674890-1ED78CE2-B8FB-4DE7-B745-B2172BB8BE02Q57822243-959C2CB1-AC73-4869-A894-4162D8FBDB7C
P2860
Efficacy and safety of gemcitabine-fluorouracil combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomized controlled trials
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Efficacy and safety of gemcita ...... f randomized controlled trials
@ast
Efficacy and safety of gemcita ...... f randomized controlled trials
@en
type
label
Efficacy and safety of gemcita ...... f randomized controlled trials
@ast
Efficacy and safety of gemcita ...... f randomized controlled trials
@en
prefLabel
Efficacy and safety of gemcita ...... f randomized controlled trials
@ast
Efficacy and safety of gemcita ...... f randomized controlled trials
@en
P2093
P2860
P1433
P1476
Efficacy and safety of gemcita ...... f randomized controlled trials
@en
P2093
P2860
P304
P356
10.1371/JOURNAL.PONE.0104346
P407
P577
2014-08-05T00:00:00Z